Phase III, Double-Blind, Placebo-Controlled Study of Post-Operative Adjuvant Concurrent Chemo-Radiotherapy With or Without Nimotuzumab for Stage III/IV Head and Neck Squamous Cell Cancer.

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 11 Jan 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

08 Jan 2024 Planned End Date changed from 1 Jan 2024 to 1 Jan 2025.
08 Jan 2024 Planned primary completion date changed from 1 Jan 2024 to 1 Jan 2025.
04 Apr 2022 Planned End Date changed from 1 Jun 2021 to 1 Jan 2024.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com